Mettler-Toledo International (MTD) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Q3 2025 delivered strong results with 8% reported sales growth (6% in local currency) and a 9% increase in adjusted EPS, driven by robust Industrial segment performance and effective execution of strategic initiatives.
The company remains agile amid global trade disputes, tariffs, and policy uncertainties, leveraging automation, digitalization, and onshoring trends for future growth.
Strongest growth was seen in the Americas and Europe, with Asia/Rest of World showing modest gains.
Service revenue outpaced product revenue growth, benefiting from acquisitions and increased demand.
Strategic investments, operational excellence, and innovation-focused strategies are expected to sustain performance in a dynamic environment.
Financial highlights
Q3 2025 sales reached $1.03 billion, up 8% year-over-year (6% in local currency); adjusted EPS was $11.15, up 9%; reported EPS was $10.57, up from $9.96.
Adjusted operating profit was $309.9 million, up 5% year-over-year; adjusted operating margin was 30.1%, down 100 bps.
Gross margin was 59.2%, down 80 bps due to tariffs and unfavorable mix.
Adjusted free cash flow for the first nine months was $689.5 million.
Operating cash flow for the nine months was $730.2 million; capital expenditures were $65.6 million.
Outlook and guidance
Q4 2025 local currency sales expected to grow ~3%; adjusted EPS guidance: $12.68–$12.88 (2–4% growth), with a 7% EPS headwind from tariffs.
Full-year 2025 local currency sales growth forecast at 2% (3.5% excluding shipping delays); adjusted EPS $42.05–$42.25 (2–3% growth, or 6–7% excluding shipping delays).
2026 guidance: local currency sales up ~4%, adjusted EPS $45.35–$46 (8–9% growth); free cash flow expected at $900 million.
Tariff headwinds expected to be fully offset in 2026 through pricing and supply chain actions.
Cash flows and liquidity are expected to be sufficient to meet foreseeable needs.
Latest events from Mettler-Toledo International
- Q2 sales fell 4% but net earnings rose 4% and full-year EPS guidance was raised.MTD
Q2 20248 Jul 2026 - 2026 guidance targets 4% revenue growth, margin expansion, and full tariff mitigation.MTD
44th Annual J.P. Morgan Healthcare Conference8 Jul 2026 - Q4 2025 delivered 8% sales and EPS growth, with a strong outlook for 2026.MTD
Q4 20258 Jul 2026 - Strong Q1 growth, tariff mitigation, and margin initiatives position the business for resilience.MTD
Bank of America 2025 Healthcare Conference8 Jul 2026 - Q4 2024 saw double-digit sales and EPS growth, with 2025 guidance tempered by headwinds.MTD
Q4 20248 Jul 2026 - Q1 sales fell 5% to $883.7M, but margin gains and lab growth offset tariff headwinds.MTD
Q1 20258 Jul 2026 - Adjusted EPS up 9% and sales up 7% in Q1 2026, with raised full-year EPS guidance.MTD
Q1 202614 May 2026 - Strong earnings, innovation, and China-led growth support a positive second-half outlook.MTD
Bank of America Global Healthcare Conference 202613 May 2026 - Annual meeting covers director elections, auditor ratification, and performance-based executive pay.MTD
Proxy Filing18 Mar 2026